The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
Open accessAbstract
The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1. Mutation of ATM occurs in the human autosomal recessive disorder ataxia-telangiectasia, which is characterized by hypersensitivity to ionizing radiation and a failure of cells to arrest the cell cycle after the induction of DNA double-strand breaks. It has thus been proposed that ATM inhibition would cause cellular radio- and chemosensitization. Through screening a small molecule compound library developed for the phosphatidylinositol 3'-kinase-like kinase family, we identified an ATP-competitive inhibitor, 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one (KU-55933), that inhibits ATM with an IC(50) of 13 nmol/L and a Ki of 2.2 nmol/L. KU-55933 shows specificity with respect to inhibition of other phosphatidylinositol 3'-kinase-like kinases. Cellular inhibition of ATM by KU-55933 was demonstrated by the ablation of ionizing radiation-dependent phosphorylation of a range of ATM targets, including p53, gammaH2AX, NBS1, and SMC1. KU-55933 did not show inhibition of UV light DNA damage induced cellular phosphorylation events. Exposure of cells to KU-55933 resulted in a significant sensitization to the cytotoxic effects of ionizing radiation and to the DNA double-strand break-inducing chemotherapeutic agents, etoposide, doxorubicin, and camptothecin. Inhibition of ATM by KU-55933 also caused a loss of ionizing radiation-induced cell cycle arrest. By contrast, KU-55933 did not potentiate the cytotoxic effects of ionizing radiation on ataxia-telangiectasia cells, nor did it affect their cell cycle profile after DNA damage. We conclude that KU-55933 is a novel, specific, and potent inhibitor of the ATM kinase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The translocation of USP10 could be blocked by the ATM inhibitor Ku55933”
From USP10 Regulates p53 Localization and Stability by Deubiquitinating p53 (2010) · cites this paper as Hickson et al., 2004
Citations
Cites
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
ATM Phosphorylates Histone H2AX in Response to DNA Double-strand Breaks
Burma, S., Chen, B. P., Murphy, M., Kurimasa, A., & Chen, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100466200 · Cited by 1,954
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Walker, E. H., Pacold, M. E., Perišić, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,211
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Stiff, T., O’Driscoll, M., Rief, N., Iwabuchi, K., Löbrich, M., & Jeggo, P. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3207 · Cited by 1,050
Research works printed but not linked: 1
- Ormerod MG Analysis of DNA-general methods Ormerod MG eds. . Flow cytometry 200083-97. Oxford University Press Oxford, UK
Cited by
Sorted by citations
Items 501–600 of 1,000
A role for AMPK in increased insulin action after serum starvation
Ching, J. K., Rajguru, P., Marupudi, N., Banerjee, S., & Fisher, J. S. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00514.2009 · Cited by 50
The Shelterin Protein TRF2 Inhibits Chk2 Activity at Telomeres in the Absence of DNA Damage
Buscemi, G., Zannini, L., Fontanella, E., Lecis, D., Lisanti, S., & Delia, D. (2009) · Current Biology · doi:10.1016/j.cub.2009.03.064 · Cited by 56
Targeting the DNA Damage Response for Cancer Therapy
Wang, R., Sun, Y., Li, C., Xue, Y., & Ba, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115907 · Cited by 50
Zizza, P., Cingolani, C., Artuso, S., Salvati, E., Rizzo, A., D’Angelo, C., Porru, M., Pagano, B., Amato, J., Randazzo, A., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1122 · Cited by 46
ATM Limits Incorrect End Utilization during Non-Homologous End Joining of Multiple Chromosome Breaks
Bennardo, N., & Stark, J. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001194 · Cited by 48
The molecular basis of ATM-dependent dimerization of the Mdc1 DNA damage checkpoint mediator
Jungmichel, S., Clapperton, J. A., Lloyd, J., Hari, F. J., Spycher, C., Pavic, L., Li, J., Haire, L. F., Bonalli, M., Larsen, D. H., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1300 · Cited by 55
Hyperoxia activates ATM independent from mitochondrial ROS and dysfunction
Resseguie, E. A., Staversky, R. J., Brookes, P. S., & O’Reilly, M. A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.04.012 · Cited by 45
Deng, S., Yan, T., Nikolova, T., Fuhrmann, D. C., Nemecek, A., Gödtel‐Armbrust, U., Kaina, B., & Wojnowski, L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13046 · Cited by 47
ATM protein is deficient in over 40% of lung adenocarcinomas
Villaruz, L. C., Jones, H., Đačić, S., Abberbock, S. R., Kurland, B. F., Stabile, L. P., Siegfried, J. M., Conrads, T. P., Smith, N. R., O’Connor, M. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9757 · Cited by 46
Schlam‐Babayov, S., Bensimon, A., Harel, M., Geiger, T., Aebersold, R. H., Ziv, Y., & Shiloh, Y. (2020) · The EMBO Journal · doi:10.15252/embj.2020104400 · Cited by 48
ATM and GLUT1-S490 Phosphorylation Regulate GLUT1 Mediated Transport in Skeletal Muscle
Andrisse, S., Patel, G. D., Chen, J. E., Webber, A. M., Spears, L. D., Koehler, R. M., Robinson-Hill, R. M., Ching, J. K., Jeong, I., & Fisher, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066027 · Cited by 48
Targeting DNA double-strand break signalling and repair: recent advances in cancer therapy
Hühn, D., Bolck, H. A., & Sartori, A. A. (2013) · Swiss Medical Weekly · doi:10.4414/smw.2013.13837 · Cited by 53
Yi, Y. W., Kang, H. J., Kim, H. J., Hwang, J. S., Wang, A., & Bae, I. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21905 · Cited by 46
Carlos, A. R., Escandell, J. M., Kotsantis, P., Suwaki, N., Bouwman, P., Badie, S., Folio, C., Benitez, J. J., Goméz-López, G., Pisano, D. G., et al. (2013) · Nature Communications · doi:10.1038/ncomms3697 · Cited by 47
Mund, A., Schubert, T., Staege, H., Kinkley, S., Reumann, K., Kriegs, M., Fritsch, L., Battisti, V., Ait‐Si‐Ali, S., Hoffbeck, A.-S., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks868 · Cited by 49
G 2 /M Cell Cycle Arrest Correlates with Primate Lentiviral Vpr Interaction with the SLX4 Complex
Berger, G., Lawrence, M., Hué, S., & Neil, S. J. D. (2014) · Journal of Virology · doi:10.1128/jvi.02307-14 · Cited by 47
Tian, X., Lara, H., Wagner, K., Saripalli, S., Hyder, S. N., Foote, M. B., Sethi, M., Wang, E. C., Caster, J. M., Zhang, L., et al. (2015) · Nanoscale · doi:10.1039/c5nr05869d · Cited by 45
Understanding specific functions of PARP-2: new lessons for cancer therapy.
Ali, S. O., Khan, F. A., Galindo-Campos, M. A., & Yélamos, J. (2016) · PubMed · Cited by 43
Monitoring ATM kinase activity in living cells
Johnson, S. A., You, Z., & Hunter, T. R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.025 · Cited by 45
Xue, L., Yu, D. S., Furusawa, Y., Okayasu, R., Tong, J., Cao, J., & Fan, S. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.06.016 · Cited by 45
Oxidative stress-induced DNA damage and cell cycle regulation in B65 dopaminergic cell line
Pizarro, J. G., Folch, J., de la Torre, A. V., Verdaguer, E., Junyent, F., Jordán, J., Pallàs, M., & Camins, A. (2009) · Free Radical Research · doi:10.1080/10715760903159188 · Cited by 45
Lee, J. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102808 · Cited by 50
Deng, Q., Sheng, L., Su, D., Zhang, L., Liu, P., Lü, K., & Ma, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9507-2 · Cited by 44
Glanzer, J. G., Liu, S., & Oakley, G. G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.012 · Cited by 44
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM
Ma, J., Setton, J. S., Morris, L. G. T., Blecua, P., Barker, C. A., Lok, B. H., Sherman, E. J., Katabi, N., Beal, K. P., Ganly, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14400 · Cited by 44
Targeting the DNA damage response for cancer therapy
Curtin, N. J. (2023) · Biochemical Society Transactions · doi:10.1042/bst20220681 · Cited by 46
Self-citationShanware, N. P., Trinh, A. T., Williams, L. M., & Tibbetts, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610674200 · Cited by 46
Development of a Cell-Based, High-Throughput Screening Assay for ATM Kinase Inhibitors
Guo, K., Shelat, A. A., Guy, R. K., & Kastan, M. B. (2014) · SLAS DISCOVERY · doi:10.1177/1087057113520325 · Cited by 44
Ward, T. A., McHugh, P. J., & Durant, S. T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179278 · Cited by 44
Nol12 is a multifunctional RNA binding protein at the nexus of RNA and DNA metabolism
Scott, D. D., Trahan, C., Zindy, P. J., Aguilar, L. C., Delubac, M. Y., Nostrand, E. L. V., Adivarahan, S., Wei, K. E., Yeo, G. W.-M., Zenklusen, D., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx963 · Cited by 43
Nagasaka, M., Hashimoto, R., Inoue, Y., Ishiuchi, K., Matsuno, M., Itoh, Y., Tokugawa, M., Ohoka, N., Morishita, D., Mizukami, H., et al. (2018) · Molecules · doi:10.3390/molecules23061394 · Cited by 45
Zhao, K., Wang, X., Xue, X., Li, L., & Hu, Y. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000666 · Cited by 44
Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models
Deland, K., Starr, B. F., Mercer, J. S., Byemerwa, J. K., Crabtree, D., Williams, N. T., Luo, L., Ma, Y., Chen, M., Becher, O. J., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci142158 · Cited by 45
Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage
Fernandez, A., Artola, M., Leon, S., Otegui, N., Jimeno, A., Serrano, D., & Calvo, A. (2025) · Cells · doi:10.3390/cells14100748 · Cited by 46
Davis, A. J., Lee, K. J., & Chen, D. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.434498 · Cited by 42
The Fanconi Anemia Protein FANCM Is Controlled by FANCD2 and the ATR/ATM Pathways
Sobeck, A., Stone, S., Landais, I., de Graaf, B., & Hoatlin, M. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007690 · Cited by 42
Min, J., Guo, K., Suryadevara, P. K., Zhu, F., Holbrook, G., Chen, Y., Féau, C., Young, B. M., Lemoff, A. S., Connelly, M., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01092 · Cited by 42
Repurposing DNA repair factors to eradicate tumor cells upon radiotherapy
Bhattacharya, S., & Asaithamby, A. (2017) · Translational Cancer Research · doi:10.21037/tcr.2017.05.22 · Cited by 44
Stephan, H., Concannon, C., Kremmer, E., Carty, M. P., & Nasheuer, H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp605 · Cited by 42
Povirk, L. F., Zhou, R.-Z., Ramsden, D. A., Lees‐Miller, S. P., & Valerie, K. C. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm339 · Cited by 42
Navrkalová, V., Šebejová, L., Zemanová, J., Kmínková, J., Kubešová, B., Malčíková, J., Mráz, M., Šmardová, J., Pavlová, Š., Doubek, M., et al. (2013) · Haematologica · doi:10.3324/haematol.2012.081620 · Cited by 41
Javvadi, P., Makino, H., Das, A. K., Lin, Y., Chen, D. J., Chen, B. P., & Nirodi, C. S. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0482-t · Cited by 41
Axitinib exposure triggers endothelial cells senescence through ROS accumulation and ATM activation
Mongiardi, M. P., Radice, G., Piras, M., Stagni, V., Pacioni, S., Re, A., Putti, S., Ferrè, F., Farsetti, A., Pallini, R., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0798-2 · Cited by 41
Fang, C., Manes, T. D., Liu, L., Liu, K., Qin, L., Li, G., Tobiásová, Z., Kirkiles-Smith, N. C., Patel, M., Merola, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10041-2 · Cited by 43
Gomez-Roman, N., Chong, M. Y., Chahal, S. K., Caragher, S. P., Jackson, M. R., Stevenson, K. H., Dongre, S. A., & Chalmers, A. J. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-1320 · Cited by 42
Chen, J.-H., Tsou, T., Chiu, I., & Chou, C.-C. (2010) · Chemical Research in Toxicology · doi:10.1021/tx1000893 · Cited by 42
Shi, Y., Cao, J., Gao, J., Zheng, L., Goodwin, A., An, C. H., Patel, A. S., Lee, J. S., Duncan, S. R., Kaminski, N., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2023oc · Cited by 42
Modulation of DNA repair by pharmacological inhibitors of the PIKK protein kinase family
Finlay, M. R. V., & Griffin, R. J. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.06.053 · Cited by 40
Stagni, V., Mingardi, M., Santini, S., Giaccari, D., & Barilà, D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq193 · Cited by 40
Hain, K. O., Colin, D., Rastogi, S., Allan, L. A., & Clarke, P. R. (2016) · Scientific Reports · doi:10.1038/srep26766 · Cited by 40
Agarwal, P., & Jackson, S. P. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.009 · Cited by 40
Self-citationWu, P., Wang, J., Chen, C., Chao, K.-Y., Chang, M.-C., Chen, W., & Hung, S. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.15-0394 · Cited by 40
Ren, S., Rehman, Z. U., Gao, B., Yang, Z., Zhou, J., Meng, C., Song, C., Nair, V., Sun, Y., & Ding, C. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008514 · Cited by 41
McFarlane, S., Nicholl, M. J., Sutherland, J. S., & Preston, C. M. (2011) · Virology · doi:10.1016/j.virol.2011.03.005 · Cited by 38
Shi, Y., Dodson, G. E., Mukhopadhyay, P. S., Shanware, N. P., Trinh, A. T., & Tibbetts, R. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609256200 · Cited by 39
SMC1-Mediated Intra-S-Phase Arrest Facilitates Bocavirus DNA Replication
Luo, Y., Deng, X., Cheng, F., Li, Y., & Qiu, J. (2013) · Journal of Virology · doi:10.1128/jvi.03396-12 · Cited by 41
Ku70/80 Modulates ATM and ATR Signaling Pathways in Response to DNA Double Strand Breaks
Tomimatsu, N., Tahimic, C. G. T., Otsuki, A., Burma, S., Fukuhara, A., Sato, K., Shiota, G., Oshimura, M., Chen, D. J., & Kurimasa, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611880200 · Cited by 42
DNA repair and synthetic lethality
Guo, G., Zhang, F., Gao, R., Delsite, R., Feng, Z., & Powell, S. N. (2011) · International Journal of Oral Science · doi:10.4248/ijos11064 · Cited by 40
Okita, R., Wolf, D., Yasuda, K., Maeda, A., Yukawa, T., Saisho, S., Shimizu, K., Yamaguchi, Y., Oka, M., Nakayama, E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139809 · Cited by 39
The role of ATM and 53BP1 as predictive markers in cervical cancer
Roossink, F., Wieringa, H. W., Noordhuis, M. G., ten Hoor, K. A., Kok, M., Slagter‐Menkema, L., Hollema, H., de Bock, G. H., Pras, E., de Vries, E. G. E., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27488 · Cited by 38
Importance of PIKKs in NF-κB activation by genotoxic stress
Sabatel, H., Pirlot, C., Piette, J. G., & Habraken, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.105 · Cited by 39
Liamin, M., Boutet-Robinet, E. A., Jamin, E. L., Fernier, M., Khoury, L., Kopp, B., Ferrec, E. L., Vignard, J., Audebert, M., & Sparfel, L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.025 · Cited by 39
Zhao, B., Zhang, W., Cun, Y., Li, J., Liu, Y., Gao, J. X., Zhu, H., Zhou, H., Zhang, R., & Zheng, P. (2017) · Cell Research · doi:10.1038/cr.2017.139 · Cited by 40
Caffeine Promotes Apoptosis in Mitotic Spindle Checkpoint-arrested Cells
Gabrielli, B. G., Chau, Y. Q., Giles, N., Harding, A. S., Stevens, F., & Beamish, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610104200 · Cited by 39
Geng, L., Huehls, A. M., Wagner, J. M., Huntoon, C. J., & Karnitz, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028862 · Cited by 39
Modulation of the DNA-damage response to HZE particles by shielding
MUKHERJEE, B., Camacho, C. V., Tomimatsu, N., MILLER, J. A., & Burma, S. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.06.016 · Cited by 38
Valli, C., Paroni, G., Francesco, A. M. D., Riccardi, R., Tavecchio, M., Erba, E., Boldetti, A., Gianni’, M., Fratelli, M., Pisano, C., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0419 · Cited by 39
Disparate Pathways for Extrachromosomal DNA Biogenesis and Genomic DNA Repair
Rose, J. C., Belk, J. A., Wong, I. T.-L., Luebeck, J., Horn, H. T., Dániel, B., Jones, M. G., Yost, K. E., Hung, K. L., Kolahi, K. S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-1117 · Cited by 38
ATR and Rad17 collaborate in modulating Rad9 localisation at sites of DNA damage
Medhurst, A. L., Warmerdam, D. O., Akerman, İ., Verwayen, E. H., Kanaar, R., Smits, V. A. J., & Lakin, N. D. (2008) · Journal of Cell Science · doi:10.1242/jcs.033688 · Cited by 39
Kubota, S., Fukumoto, Y., Ishibashi, K., Soeda, S., Kubota, S., Yuki, R., Nakayama, Y., Aoyama, K., Yamaguchi, N., & Yamaguchi, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.546655 · Cited by 38
Nair, R. R., Bagheri, M., & Saini, D. K. (2014) · Journal of Cell Science · doi:10.1242/jcs.159517 · Cited by 38
Barlaam, B. C., Cadogan, E. B., Campbell, A. D., Colclough, N., Dishington, A. P., Durant, S. T., Goldberg, K., Hassall, L. A., Hughes, G. D., MacFaul, P. A., et al. (2018) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.8b00200 · Cited by 38
You, K. S., Yi, Y. W., Cho, J., & Seong, Y. (2021) · Cancers · doi:10.3390/cancers13061205 · Cited by 37
Berglund, F. M., & Clarke, P. R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.019 · Cited by 38
Dual Functions of ASCIZ in the DNA Base Damage Response and Pulmonary Organogenesis
Jurado, S., Smyth, I., van Denderen, B., Tenis, N., Hammet, A., Hewitt, K. A., Ng, J.-L., McNees, C. J., Kozlov, S., Oka, H., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001170 · Cited by 39
DNA repair inhibitors in cancer treatment
Sánchez‐Pérez, I. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0034-8 · Cited by 38
DNA damage-induced signalling in ataxia-telangiectasia and related syndromes
Lavin, M. F., & Kozlov, S. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.04.032 · Cited by 40
Mao, W.-W., Wang, T., Zeng, H., Wang, Z., Chen, J., & Shen, J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.06.098 · Cited by 38
McKerlie, M., Lin, S., & Zhu, X. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks035 · Cited by 42
ΔNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation
Craig, A. L., Holcakova, J., Finlan, L. E., Nekulova, M., Hrstka, R., Gueven, N., DiRenzo, J., Smith, G., Hupp, T. R., & Vojtesek, B. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-195 · Cited by 37
Self-citationPhosphorylation of SRSF1 is modulated by replicational stress
Leva, V., Giuliano, S., Bardoni, A., Camerini, S., Crescenzi, M., Lisa, A., Biamonti, G., & Montecucco, A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr837 · Cited by 37
H2AX a Promising Biomarker for Lung Cancer: A Review
Matthaios, D., Hountis, P. G., Karakitsos, P., Bouros, D. E., & Kakolyris, S. (2013) · Cancer Investigation · doi:10.3109/07357907.2013.849721 · Cited by 40
Sunada, S., Kanai, H., Lee, Y., Yasuda, T., Hirakawa, H., Liu, C., Fujimori, A., Uesaka, M., & Okayasu, R. (2016) · Cancer Science · doi:10.1111/cas.12998 · Cited by 38
Li, K., Yan, H., Guo, W., Tang, M., Zhao, X., Tong, A., Peng, Y., Li, Q., & Yuan, Z. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.03.006 · Cited by 38
DNA Repair: Translation to the Clinic
Minten, E. V., & Yu, D. S. (2019) · Clinical Oncology · doi:10.1016/j.clon.2019.02.007 · Cited by 36
Chronic irradiation of human cells reduces histone levels and deregulates gene expression
Lowe, D., Herzog, M., Mosler, T., Cohen, H., Felton, S. J., Beli, P., Raj, K., Galanty, Y., & Jackson, S. P. (2020) · Scientific Reports · doi:10.1038/s41598-020-59163-4 · Cited by 40
Self-citationCollaco, R. F., Bevington, J. M., Bhrigu, V., Kalman‐Maltese, V., & Trempe, J. P. (2009) · Virology · doi:10.1016/j.virol.2009.06.005 · Cited by 40
PTIP/Swift is required for efficient PCNA ubiquitination in response to DNA damage
Göhler, T., Munoz, I. M., Rouse, J. W., & Blow, J. J. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.02.001 · Cited by 37
Revisiting p53 for cancer-specific chemo- and radiotherapy
Beckta, J. M., Ahmad, S. F., Yang, H., & Valerie, K. C. (2014) · Cell Cycle · doi:10.4161/cc.28108 · Cited by 36
The ATM regulated DNA damage response pathway as a chemo- and radiosensitisation target
Alao, J. P. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440902835475 · Cited by 36
Carlessi, L., Buscemi, G., Fontanella, E., & Delia, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.002 · Cited by 36
Liemburg-Apers, D. C., Wagenaars, J. A. L., Smeitink, J. A. M., Willems, P. H. G. M., & Koopman, W. J. H. (2016) · Journal of Cell Science · doi:10.1242/jcs.194480 · Cited by 35
Cytoplasmic ATR Activation Promotes Vaccinia Virus Genome Replication
Postigo, A. A., Ramsden, A. E., Howell, M. T., & Way, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.025 · Cited by 38
BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase
Justice, J., Needham, J. M., & Thompson, S. R. (2019) · Journal of Virology · doi:10.1128/jvi.00130-19 · Cited by 37
Kuroda, S., Urata, Y., & Fujiwara, T. (2012) · PubMed · doi:10.18926/amo/48258 · Cited by 36
ATM Mediates Cytotoxicity of a Mutant Telomerase RNA in Human Cancer Cells
Stohr, B. A., & Blackburn, E. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0504 · Cited by 37
Bandarra, S., Fernandes, A. S., dos Reis, I. M., Guerreiro, P. S., Pingarilho, M., Churchwell, M. I., Gil, O. M., Batinic-Haberle, I., Goncalves, S., Rueff, J., et al. (2013) · Mutagenesis · doi:10.1093/mutage/get052 · Cited by 36
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage
Nappi, A., Miro, C., Pezone, A., Tramontano, A., Cicco, E. D., Sagliocchi, S., Cicatiello, A. G., Murolo, M., Torabinejad, S., Abbotto, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36755-y · Cited by 35
Small Molecule Inhibitors of the PI3-Kinase Family
Knight, Z. A. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_44 · Cited by 35
Direct Activation of ATM by Resveratrol under Oxidizing Conditions
Lee, J., Guo, Z., Myler, L. R., Zheng, S., & Paull, T. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097969 · Cited by 38
Metadata
- Authors
- Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M.
- Affiliations
- 1KuDOS Pharmaceuticals Ltd., Cambridge Science Park, Milton Road, Cambridge;
- Newcastle University (GB)
- University of Cambridge (GB)
- ORCID
- Venue
- Cancer Research
- Published
- 2004-12-15
- Volume
- 64
- Issue
- 24
- Pages
- 9152-9159
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2101988823
- Cited by
- 1,220
- References
- 58
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 38 · 2023: 49 · 2022: 31 · 2021: 32 · 2020: 53 · 2019: 55 · 2018: 48 · 2017: 66 · 2016: 71 · 2015: 76 · 2014: 70 · 2013: 62 · 2012: 92
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- ATM kinase, KU55933, kinase inhibitors, ataxia telangiectasia, radiosensitivity, DNA double-strand breaks, cell cycle arrest, p53 phosphorylation, NBS1, radiosensitization, chemosensitization, etoposide, doxorubicin, camptothecin, γH2AX, SMC1A
- MeSH terms
- Cell Cycle, Chromones, DNA-Binding Proteins, HeLa Cells, Humans, Kinetics, Morpholines, Phosphorylation, Pyrones, Radiation-Sensitizing Agents, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Inhibitory Concentration 50, Combinatorial Chemistry Techniques, Tumor Suppressor Proteins, Cell Line, Tumor, Protein Kinase Inhibitors, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review